This is an unofficial transcript of Warren Buffett's April 23, 2014 live appearance on CNBC's "Closing Bell"» Read More
Moshe Cohen, Columbia Business School professor, explains why he thinks Apple has limited foresight, and why consumers are losing faith in the ability of its new leadership.
Discussing Apple's 7-for-1 stock split effective June 9, and the company's bad tablet number, with Max Wolff, Citizen VC chief economist, and Gene Munster, Piper Jaffray senior research analyst.
Apple is reporting Q2 EPS of $11.62 on revenue of $45.6 billion. Gene Munster, Piper Jaffray senior research analyst, says investors should feel a sense of relief on these numbers.
CNBC's Seema Mody provides detail from the afternoon earnings data from Facebook, Zynga, Qualcomm and F5 Networks.
Apple is reporting Q2 EPS of $11.62 on revenue of $45.6 billion, with CNBC's Josh Lipton. The company beat on the top and bottom lines. iPhone sales were particularly strong.
Analyzing Facebook's Q1 earnings, with Darren Chervitz, The Jacob Internet Fund; David Garrity, GVA Research; and Jon Steinberg, BuzzFeed.
Zynga reported a Q1 loss of ($0.01) ex-items on revenue of $161 million, with CNBC's Morgan Brennan. The company beat on the topline.
The "Closing Bell" crew react to Facebook's Q1 earnings data, and the announcement the company's CFO David Ebersman is stepping down.
Facebook is reporting Q1 EPS of $0.34 ex-items on revenue of $2.5 billion, with CNBC's Morgan Brennan.
Gina Sanchez, Chantico Global chairwoman & founder, and Steve Sachs, ProShares Advisors head of capital markets, discuss Apple earnings and the overall health of the tech sector.
Discussing ugly earnings in Q1 and expectations for Apple, with Gina Sanchez, Chantico Global chairwoman & founder, and Steve Sachs, ProShares Advisors head of capital markets.
Vocalist Fergie of The Black Eyed Peas is on the floor at the NYSE to ring the closing bell.
Coca-Cola's board of directors responds to Warren Buffett's opposition to its equity plan, reports CNBC's Sara Eisen.
CNBC's Meg Tirrell speaks with George Scangos, Biogen Idec CEO, about the drug maker's fight against MS and Alzheimer's. Scangos also comments on Valeant's bid for Alllergan.
CNBC's Becky Quick discusses Warren Buffett's feelings about Coke, IBM and his general sentiment about the market.
CNBC's Becky Quick discusses Warren Buffett's feelings about the market.
Warren Buffett discusses activist investing and shares his thoughts on David Winters and Bill Ackman.
CNBC's Becky Quick speaks with Warren Buffett about his position in IBM after its disappointing earnings report. I've bought stock this year and have never sold a share, Buffett said.
CNBC's Becky Quick speaks with Warren Buffett about why he abstained in his vote on Coke shareholder equity plan. The package was excessive, he says.
CNBC's Becky Quick speaks with Warren Buffett about why he abstained from voting on Coca-Cola's executive-compensation plan and responds to activist investor David Winters criticism. "We didn't disapprove of management, but we did disapprove of the plan," Buffett said.